We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immune Deficiency Due to Defective DNA Repair

By Biotechdaily staff writers
Posted on 22 May 2002
A mutation in a gene whose product is responsible for repair of damaged DNA molecules is the underlying cause of a form of severe immunodeficiency. More...
This finding is reported in a study published in the March 22, 2002, issue of Cell.

The gene was first described in April of 2001 by a team of French researchers who named it and its product Artemis (after the Greek goddess for the protection of children). However, they did not report what kind of protein it was nor what its function might be.

Now, Dr. Michael Lieber from the Keck School of Medicine at the University of Southern California (Los Angeles CA, USA) and his colleagues from the University of Ulm (Germany; www.uni-ulm.de) have conclusively demonstrated that Artemis is a key protein in the repair of damage to double-stranded DNA, a process called NHEJ (nonhomologous DNA end joining). In the NHEJ pathway, the ends of the broken DNA strands are trimmed and rejoined to one another. "What Artemis does is trim away the damaged parts of the DNA so that the strands can be joined,” said Lieber.

Artemis and the NHEJ pathway are so essential that mice lacking NHEJ usually die at birth. Those that survive generally lack an immune system entirely and experience accelerated aging. Humans with a defective Artemis protein suffer from practically nonfunctional immune systems. "That is because the immune system creates its defenses by cutting and then rejoining bits of nuclear DNA (the rejoining relies on NHEJ),” says Lieber. "Without Artemis, the cells cannot create the antibodies necessary to go after the myriad pathogenic invaders we regularly encounter.”

For normal cells, Artemis and the NHEJ pathway are absolutely critical for survival. Lieber explains this is because of the extreme vulnerability of our cells to DNA damage. "Indeed,” he said, "all you have to do is take some cells out of the organism in which they live and look at them under a microscope, and you will find that 5-10% of them will have at least one broken chromosome.”




Related Links:
USC, Keck School of Medicine
University of Ulm

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.